5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → 5-[3-(1,1-Difluoro-ethyl)-4-fluoro-phenyl]-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine Hydrochloride
反応式
[F:1][C:2]([C:5]1[CH:6]=[C:7](B2OC(C)(C)C(C)(C)O2)[CH:8]=[CH:9][C:10]=1[F:11])([F:4])[CH3:3].[Cl:21][C:22]1[CH:23]=[C:24]([CH2:28][N:29]2[CH:33]=[CH:32][N:31]=[C:30]2[CH3:34])[N:25]=[N:26][CH:27]=1>>[ClH:21].[F:4][C:2]([C:5]1[CH:6]=[C:7]([C:22]2[CH:23]=[C:24]([CH2:28][N:29]3[CH:33]=[CH:32][N:31]=[C:30]3[CH3:34])[N:25]=[N:26][CH:27]=2)[CH:8]=[CH:9][C:10]=1[F:11])([F:1])[CH3:3]参加物
3
実験手順
The title compound, MS: m/e=333.3 (M+H+), was prepared from 2-[3-(1,1-difluoro-ethyl)-4-fluoro-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.
出典と根拠
- ORDレコード
- ord-10e5fe294e2e4ff8abb2f21b7e6b63cd
- 出典データセット
- uspto-grants-2006_02
- DOI